Changes in Tumor-Infiltrating Lymphocytes and Inflammatory Blood Factors during Chemoradiation Therapy in Rectal Cancer
It was suggested that changes in CD4+ TILs immediately after treatment initiation and changes in inflammatory blood factors during treatment may be useful for predicting the reduction rate and TRG. These changes begin early during treatment and may be useful in predicting efficacy.
Authors
- Hajime Kayano (ORCID: https://orcid.org/0000-0002-8304-1136)
- Hiroshi Miyakita (ORCID: https://orcid.org/0000-0001-6541-2944)
- Takashi Ogimi (ORCID: https://orcid.org/0000-0001-9819-5149)
- Seiichiro Yamamoto (ORCID: https://orcid.org/0000-0002-9879-1239)
- Masaki Mori
Institutions
- Tokai University (JP)
Publication Details
- Journal
- Oncology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1159/000545312
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00